Oxaliplatin Treatment Alters Systemic Immune Responses

PURPOSE: Oxaliplatin is a platinum-based chemotherapeutic agent demonstrating significant antitumor efficacy. Unlike conventional anticancer agents which are immunosuppressive, oxaliplatin has the capacity to stimulate immunological effects in response to the presentation of damage associated molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Stojanovska, Vanesa, Prakash, Monica, McQuade, Rachel, Fraser, Sarah, Apostolopoulos, Vasso, Sakkal, Samy, Nurgali, Kulmira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398049/
https://www.ncbi.nlm.nih.gov/pubmed/30906773
http://dx.doi.org/10.1155/2019/4650695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398049/
https://www.ncbi.nlm.nih.gov/pubmed/30906773
http://dx.doi.org/10.1155/2019/4650695

Ejemplares similares